Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$484.20.8%
Market Cap$124.7B
86.1%
Industry median - 78.2%
5Y Historical average - 87.6%
2.3%
Industry median - (129.8%)
5Y Historical average - 37.4%
(7.2%)
Industry median - (114.4%)
5Y Historical average - 32.3%
147.6%
Industry median - 86.6%
5Y Historical average - 126.7%
VRTX Profitability Rating
Crunching data... Almost there!
VRTX Profitability Metrics
Crunching data... Almost there!
Competing with VRTX Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Vertex Pharmaceuticals Incorporated (VRTX) gross profit margin?
The Vertex Pharmaceuticals Incorporated (VRTX) gross profit margin is 86.1%, compared to the industry median of 78.2% and the 5-year historical average of 87.6%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) operating income margin?
The Vertex Pharmaceuticals Incorporated (VRTX) operating income margin is 2.3%, compared to the industry median of (129.8%)) and the 5-year historical average of 37.4%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow (FCF) margin?
The Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow margin is (7.2%), compared to the industry median of (114.4%) and the 5-year historical average of 32.3%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) earnings quality?
The Vertex Pharmaceuticals Incorporated (VRTX) earnings quality is 147.6%, compared to the industry median of 86.6% and the 5-year historical average of 126.7%.